Viral Specific T-cells (VSTs) for virus diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Apr 2020: Trial registered, NCT04331275
  2. 18 Aug 2020: Trial started, NCT04331275

The trials

NCT04331275: Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant

State
Under way
Phase
Phase 2
People
42 taking part
Started
18 Aug 2020
Primary completion
Sep 2030
Arms
Viral Specific T-cells (VSTs)
Results
None posted
  1. 2 Apr 2020: Trial registered
  2. 18 Aug 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.